Myocarditis began with vaccine rollout

Although there have been several epidemiological analyses of myocarditis, that simple comparison is never made. Where uninjected people are looked at specifically, there is no evidence of an increase in incidence. HART has previously summarised the data after infection in the injected compared to the uninjected.

An alternative approach is to look at how common myocarditis is over time. Did the incidence increase with the arrival of covid in 2020 or the arrival of injections in 2021?

Read More

Have the MHRA admitted causation for any vaccine harm?

The MHRA are far too slow to react to harm and admit causation. There is a history here. When the 2009 swine flu vaccine caused narcolepsy the UK institutions were very slow to react. It was Scandinavian countries who highlighted the problem in 2010. That year the MHRA were measuring for other effects but not narcolepsy. In 2011, they said they needed to await epidemiological studies. It took until 2013 before Public Health England admitted a problem in the UK.

Read More

When money and ethics collide

Last month, HART wrote an article on the spring booster programme, including linking to an article in Chemist+Druggist on the pending availability of private covid vaccines in pharmacies up and down the land. A company called Pharmadoctor was the first into the ring but has been followed by others including Boots, the oldest of the UK high street chemists, whose strapline on their website is: We serve your wellbeing for life.

Read More